Springer Nature
Browse
12962_2020_205_MOESM6_ESM.docx (69.2 kB)

Additional file 6 of Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective

Download (69.2 kB)
journal contribution
posted on 2020-02-11, 05:31 authored by Sarah Dewilde, Kevin Carroll, Emilia Nivelle, James Sawyer
Additional file 6. Base case results per country, all anthracycline doses. Table showing the base case results for Germany, Italy, Spain and the United Kingdom.

Funding

Clinigen Group PLC

History

Usage metrics

    Cost Effectiveness and Resource Allocation

    Categories

    Keywords

    Cost-effectivenessDexrazoxanePreventionAnthracyclineCardiotoxicitySarcomaHaematologic malignancy

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC